15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Xperi Corp, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $10.00 to $12.00, so the covering firms are broadly aligned. The average target of $11.00 sits 44% above the current $7.64. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.21 next quarter toward $1.24 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Xperi Corp.
As of Jul, 3 of 3 firms rate XPER a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
XPER EPS & revenue forecast
EPS · NEXT QUARTER
$0.21
Range $0.13 – $0.29 · 5 analysts · -27% YoY
Next period, 5 analysts expect Xperi Corp to earn $0.21 a share (range $0.13 – $0.29), versus $0.28 a year earlier. Full-year consensus is $0.91, growing to $1.24 the year after.
REVENUE · NEXT QUARTER
$112.8M
Range $109.4M – $116.6M · 5 analysts · +1% YoY
Revenue is expected to reach $112.8M (range $109.4M – $116.6M), +1.1% year-over-year. Full-year consensus is $457.3M, rising to $489.5M next year.
Top analysts covering Xperi Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XPER.
#1
Hamed Khorsand
BWS Financial · Rank #14
Buy
$12.00+57.1% to target
Overall win rate
52%
+ Follow
#2
Jason Kreyer
Craig-Hallum · Rank #376
Buy
$12.00+57.1% to target
Overall win rate
21%
+ Follow
#3
SF
Steven Frankel
Rosenblatt
Buy
$10.00+30.9% to target
Coverage
—
+ Follow
XPER stock forecast FAQ
What is XPER's average 12-month price target?+
The 2 analysts with a live target average $11.00 for Xperi Corp over the next 12 months, ranging from a $12.00 high to a $10.00 low.
Is XPER stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for XPER?+
The Street-high target is $12.00 (BWS Financial), and the Street-low is $10.00 (Rosenblatt). The average of all 2 active targets is $11.00.
How many Wall Street analysts cover XPER?+
3 analysts have an active rating on Xperi Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering XPER?+
Among analysts who currently cover XPER, Hamed Khorsand of BWS Financial has the strongest overall Quantellect track record (Rank #14). Their current call is Buy with a $12.00 target.
What is Xperi Corp's projected EPS for next quarter?+
The consensus estimate is $0.21 per share (range $0.13 – $0.29) across 5 analysts. Full-year EPS is projected at $0.91, rising to $1.24 the following year.
How much revenue is Xperi Corp expected to report next quarter?+
Consensus revenue is $112.8M (range $109.4M – $116.6M). Full-year revenue is projected at $457.3M, growing to $489.5M next year.
Have analysts been upgrading or downgrading XPER lately?+
As of Jul, 3 of 3 firms rate XPER a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XPER calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
